{"entity":{"type":"insider","cik":"0001253803","url":"/insider/0001253803","json_url":"/insider/0001253803.json","name":"CERRONE GABRIEL","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":21,"first":"2004-12-07","last":"2013-10-29","span_basis":"filed_date"},"name_variants":[{"name":"CERRONE GABRIEL","source":"filing","n_filings":21,"first_seen":"2004-12-07","last_seen":"2013-10-29"}],"transactions":[{"id":4810556,"accession":"0001104659-13-078633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-078633","line_url":"/filing/0001104659-13-078633#line-1","is_derivative":false,"issuer_cik":"0001253803","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001253803","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":4.09,"price_display":"4.09","price_state":"stated","total_value":49080.0,"total_display":"49,080.00","total_whole":"49,080","shares_owned_after":918873.0,"shares_owned_after_display":"918,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-10-29","scope":"insider"},{"id":5316822,"accession":"0001104659-13-049229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-049229","line_url":"/filing/0001104659-13-049229#line-1","is_derivative":false,"issuer_cik":"0001253803","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001253803","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":4.42,"price_display":"4.42","price_state":"stated","total_value":35360.0,"total_display":"35,360.00","total_whole":"35,360","shares_owned_after":906873.0,"shares_owned_after_display":"906,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-14","scope":"insider"},{"id":5557806,"accession":"0001104659-13-032037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-032037","line_url":"/filing/0001104659-13-032037#line-1","is_derivative":false,"issuer_cik":"0001253803","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001253803","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":4.46,"price_display":"4.46","price_state":"stated","total_value":55750.0,"total_display":"55,750.00","total_whole":"55,750","shares_owned_after":893373.0,"shares_owned_after_display":"893,373","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-24","filed_date":"2013-04-24","scope":"insider"},{"id":4631607,"accession":"0001104659-13-032075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-032075","line_url":"/filing/0001104659-13-032075#line-1","is_derivative":false,"issuer_cik":"0001253803","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001253803","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":4.6568,"price_display":"4.66","price_state":"stated","total_value":25612.4,"total_display":"25,612.40","total_whole":"25,612","shares_owned_after":898.873,"shares_owned_after_display":"898.87","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-24","filed_date":"2013-04-24","scope":"insider"},{"id":5005809,"accession":"0001104659-13-007379","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-13-007379","line_url":"/filing/0001104659-13-007379#line-2","is_derivative":false,"issuer_cik":"0001253803","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001253803","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":6.1777,"price_display":"6.18","price_state":"stated","total_value":24710.8,"total_display":"24,710.80","total_whole":"24,711","shares_owned_after":880873.0,"shares_owned_after_display":"880,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-02-05","filed_date":"2013-02-05","scope":"insider"},{"id":5242618,"accession":"0001104659-13-007045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-007045","line_url":"/filing/0001104659-13-007045#line-1","is_derivative":false,"issuer_cik":"0001253803","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001253803","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13090.0,"shares_display":"13,090","price_per_share":6.0378,"price_display":"6.04","price_state":"stated","total_value":79034.802,"total_display":"79,034.80","total_whole":"79,035","shares_owned_after":875873.0,"shares_owned_after_display":"875,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-02-04","filed_date":"2013-02-04","scope":"insider"},{"id":5005804,"accession":"0001104659-13-007379","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-007379","line_url":"/filing/0001104659-13-007379#line-1","is_derivative":false,"issuer_cik":"0001253803","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001253803","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.04,"price_display":"6.04","price_state":"stated","total_value":6040.0,"total_display":"6,040.00","total_whole":"6,040","shares_owned_after":876873.0,"shares_owned_after_display":"876,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-02-04","filed_date":"2013-02-05","scope":"insider"},{"id":9223229,"accession":"0001104659-13-006700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-006700","line_url":"/filing/0001104659-13-006700","is_derivative":false,"issuer_cik":"0001347613","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001347613","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26000.0,"shares_display":"26,000","price_per_share":5.982461538461538,"price_display":"5.98","price_state":"stated","total_value":155544.0,"total_display":"155,544.00","total_whole":"155,544","shares_owned_after":842783.0,"shares_owned_after_display":"842,783","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-01-30","filed_date":"2013-02-01","scope":"insider","n_lines":2},{"id":3430741,"accession":"0001104659-12-084986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-084986","line_url":"/filing/0001104659-12-084986#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"TrovaGene Inc.","issuer_ticker":"TROV","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":719526.0,"shares_owned_after_display":"719,526","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-10","filed_date":"2012-12-18","scope":"insider"},{"id":3513310,"accession":"0001104659-12-078129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-078129","line_url":"/filing/0001104659-12-078129#line-1","is_derivative":false,"issuer_cik":"0001253803","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001253803","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":87820.0,"shares_display":"87,820","price_per_share":3.6125,"price_display":"3.61","price_state":"stated","total_value":317249.75,"total_display":"317,249.75","total_whole":"317,250","shares_owned_after":443760.0,"shares_owned_after_display":"443,760","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-11-14","filed_date":"2012-11-15","scope":"insider"},{"id":2541890,"accession":"0001104659-12-058850","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-12-058850","line_url":"/filing/0001104659-12-058850#line-2","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"TrovaGene Inc.","issuer_ticker":"TROV","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":2.36,"price_display":"2.36","price_state":"stated","total_value":17700.0,"total_display":"17,700.00","total_whole":"17,700","shares_owned_after":679526.0,"shares_owned_after_display":"679,526","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-08-20","filed_date":"2012-08-20","scope":"insider"},{"id":2541886,"accession":"0001104659-12-058850","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-058850","line_url":"/filing/0001104659-12-058850#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"TrovaGene Inc.","issuer_ticker":"TROV","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":645.0,"total_display":"645.00","total_whole":"645","shares_owned_after":672026.0,"shares_owned_after_display":"672,026","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-08-17","filed_date":"2012-08-20","scope":"insider"},{"id":3364822,"accession":"0001104659-12-058599","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-058599","line_url":"/filing/0001104659-12-058599#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"TrovaGene Inc.","issuer_ticker":"TROV","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.2421,"price_display":"2.24","price_state":"stated","total_value":33631.5,"total_display":"33,631.50","total_whole":"33,632","shares_owned_after":671726.0,"shares_owned_after_display":"671,726","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-08-16","filed_date":"2012-08-17","scope":"insider"},{"id":3112877,"accession":"0001104659-12-025725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-025725","line_url":"/filing/0001104659-12-025725#line-1","is_derivative":false,"issuer_cik":"0001213037","issuer_name":"TrovaGene Inc.","issuer_ticker":"TROV","issuer_name_source":null,"issuer_url":"/issuer/0001213037","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":3940356.0,"shares_owned_after_display":"3,940,356","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-13","filed_date":"2012-04-16","scope":"insider"},{"id":8982148,"accession":"0001104659-11-064130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-11-064130","line_url":"/filing/0001104659-11-064130#line-1","is_derivative":false,"issuer_cik":"0001253803","issuer_name":"SYNERGY PHARMACEUTICALS, INC.","issuer_ticker":"SGYP","issuer_name_source":null,"issuer_url":"/issuer/0001253803","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":470588.0,"shares_display":"470,588","price_per_share":2.125,"price_display":"2.12","price_state":"stated","total_value":999999.5,"total_display":"999,999.50","total_whole":"1,000,000","shares_owned_after":845527.0,"shares_owned_after_display":"845,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-11-14","filed_date":"2011-11-15","scope":"insider"},{"id":7659362,"accession":"0001104659-10-058934","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-10-058934","line_url":"/filing/0001104659-10-058934#line-1","is_derivative":false,"issuer_cik":"0001142380","issuer_name":"CALLISTO PHARMACEUTICALS INC","issuer_ticker":"CLSP","issuer_name_source":null,"issuer_url":"/issuer/0001142380","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12935.0,"shares_display":"12,935","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":3492727.0,"shares_owned_after_display":"3,492,727","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-15","filed_date":"2010-11-17","scope":"insider"},{"id":1215307,"accession":"0001321543-05-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001321543-05-000004","line_url":"/filing/0001321543-05-000004#line-1","is_derivative":false,"issuer_cik":"0001142380","issuer_name":"CALLISTO PHARMACEUTICALS INC","issuer_ticker":"KAL","issuer_name_source":null,"issuer_url":"/issuer/0001142380","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":2126737.0,"shares_owned_after_display":"2,126,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-06-09","filed_date":"2005-06-13","scope":"insider"},{"id":9209961,"accession":"0000930413-05-004182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-05-004182","line_url":"/filing/0000930413-05-004182#line-1","is_derivative":false,"issuer_cik":"0001253803","issuer_name":"CALLISTO PHARMACEUTICALS INC","issuer_ticker":"KAL","issuer_name_source":null,"issuer_url":"/issuer/0001253803","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":0.0,"shares_display":"0","price_per_share":1.02,"price_display":"1.02","price_state":"stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":2121737.0,"shares_owned_after_display":"2,121,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-06-03","filed_date":"2005-06-07","scope":"insider"},{"id":1210763,"accession":"0000930413-05-004145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-05-004145","line_url":"/filing/0000930413-05-004145#line-1","is_derivative":false,"issuer_cik":"0001142380","issuer_name":"CALLISTO PHARMACEUTICALS INC","issuer_ticker":"KAL","issuer_name_source":null,"issuer_url":"/issuer/0001142380","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":1.02,"price_display":"1.02","price_state":"stated","total_value":6120.0,"total_display":"6,120.00","total_whole":"6,120","shares_owned_after":2127737.0,"shares_owned_after_display":"2,127,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-06-03","filed_date":"2005-06-06","scope":"insider"},{"id":1622393,"accession":"0000930413-05-004103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-05-004103","line_url":"/filing/0000930413-05-004103#line-1","is_derivative":false,"issuer_cik":"0001142380","issuer_name":"CALLISTO PHARMACEUTICALS INC","issuer_ticker":"KAL","issuer_name_source":null,"issuer_url":"/issuer/0001142380","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":0.997,"price_display":"1.00","price_state":"stated","total_value":7976.0,"total_display":"7,976.00","total_whole":"7,976","shares_owned_after":2121737.0,"shares_owned_after_display":"2,121,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-05-27","filed_date":"2005-06-01","scope":"insider"},{"id":1675700,"accession":"0000930413-05-003756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-05-003756","line_url":"/filing/0000930413-05-003756#line-1","is_derivative":false,"issuer_cik":"0001142380","issuer_name":"CALLISTO PHARMACEUTICALS INC","issuer_ticker":"KAL","issuer_name_source":null,"issuer_url":"/issuer/0001142380","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":1.02,"price_display":"1.02","price_state":"stated","total_value":12750.0,"total_display":"12,750.00","total_whole":"12,750","shares_owned_after":2113737.0,"shares_owned_after_display":"2,113,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-05-19","filed_date":"2005-05-23","scope":"insider"},{"id":1541068,"accession":"0000930413-05-001786","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-05-001786","line_url":"/filing/0000930413-05-001786#line-1","is_derivative":false,"issuer_cik":"0001142380","issuer_name":"CALLISTO PHARMACEUTICALS INC","issuer_ticker":"KAL","issuer_name_source":null,"issuer_url":"/issuer/0001142380","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":38000.0,"total_display":"38,000.00","total_whole":"38,000","shares_owned_after":2101237.0,"shares_owned_after_display":"2,101,237","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-03-09","filed_date":"2005-03-11","scope":"insider"},{"id":555541,"accession":"0001125282-04-006100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001125282-04-006100","line_url":"/filing/0001125282-04-006100","is_derivative":false,"issuer_cik":"0001142380","issuer_name":"CALLISTO PHARMACEUTICALS INC","issuer_ticker":"KAL","issuer_name_source":null,"issuer_url":"/issuer/0001142380","owner_cik":"0001253803","owner_name":"CERRONE GABRIEL","owner_display_name":"CERRONE GABRIEL","owner_url":"/insider/0001253803","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27000.0,"shares_display":"27,000","price_per_share":1.5074074074074073,"price_display":"1.51","price_state":"stated","total_value":40700.0,"total_display":"40,700.00","total_whole":"40,700","shares_owned_after":2076237.0,"shares_owned_after_display":"2,076,237","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-03","filed_date":"2004-12-07","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":25,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347613","name":"SYNERGY PHARMACEUTICALS, INC.","url":"/issuer/0001347613","role":"Director, Officer (Chairman), Other","n_filings":9,"first_seen":"2011-11-15","last_seen":"2013-10-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001213037","name":"TrovaGene Inc.","url":"/issuer/0001213037","role":"Director","n_filings":4,"first_seen":"2012-04-16","last_seen":"2012-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001142380","name":"CALLISTO PHARMACEUTICALS INC","url":"/issuer/0001142380","role":"Director, Officer (Chairman)","n_filings":8,"first_seen":"2004-12-07","last_seen":"2010-11-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001253803","retrieved_at":"2026-08-24T16:41:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}